A new cell culture platform allows researchers to observe never-before-seen behaviors of live cancer cells under the microscope, leading to explanations of long-known cancer characteristics. The easy-to-produce platform developed by Hokkaido University researchers offers cancer cells micro-scale attachment sites that elicit never-before-seen behaviors highly relevant to cancer’s clinical properties. The observation of these behaviors shed […]Continue Reading ...
When a loved one has cancer, many of us turn to thoughts of comfort and help. (I’m Scandinavian by background, so I immediately warm up my formidable arsenal of casserole recipes.) But when the loved one is also a close relative, we also wonder whether there’s a genetic link that could affect others in the […]Continue Reading ...
Sep 19 2018 Having high levels of anti-Müllerian hormone (AMH) – a hormone that indicates the size of a woman’s ovarian reserve – before the menopause is associated with an increased risk of breast cancer, new research suggests. In a major new study, leading scientists from NYU School of Medicine analysed blood samples from participants […]Continue Reading ...
Vitamin D is already well known for its benefits in building healthy bones. A new study supports the idea that it also may reduce cancer risk as well as breast cancer mortality, especially in women with a lower body mass index. Study results are published online today in Menopause, the journal of The North American […]Continue Reading ...
BERKELEY HEIGHTS, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer biology, announced the initiation of a Phase 1b/2 investigator-sponsored clinical trial to evaluate the safety and effectiveness of sapacitabine in combination with olaparib in patients with BRCA mutant […]Continue Reading ...
Biomedical scientists at the University of Salford found that sugars from the common cockle (Cerastoderma edule) were approximately as effective as some standard chemotherapy drugs at relative lower dosage. And they say ‘cockle-chemo’ could be particularly suitable for children as it is potentially less toxic and less likely to cause unhealthy side-effects. Publishing in the […]Continue Reading ...
Pancreatic cancer is currently very difficult to detect while it is still resectable. A new blood test developed by researchers at Lund University in Sweden, Herlev Hospital, Knight Cancer Center and Immunovia AB, can detect pancreatic cancer in the very earliest stages of the disease. The results have been published in the Journal of Clinical […]Continue Reading ...
A research team at the University of Turku in Finland discovered a link between the interplay of certain simultaneously occurring genetic changes in the HOXB13 and CIP2A genes, aggressiveness of prostate cancer, high risk of developing the disease, and poorer survival rates of patients. Prostate cancer is a major challenge in health care with over […]Continue Reading ...
An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer. These results were presented as a […]Continue Reading ...
A little p63 goes a long way in embryonic development – and flaws in p63 can result in birth defects like cleft palette, fused fingers or even missing limbs. But once this early work is done, p63 goes silent, sitting quietly in the genome from that point forward. Unless it is accidentally reactivated. When p63 […]Continue Reading ...
An Ontario clinical study that shows adding PET imaging to conventional CT imaging to stage locally advanced cervix cancer can change treatment means newly diagnosed women in this province may also receive PET imaging. The findings are published online today by JAMA Network Open. Co-principal investigators Dr. Anthony Fyles, radiation oncologist at Princess Margaret Cancer […]Continue Reading ...
An online initiative offering low-cost genetic testing to relatives of people with genetic mutations that increase their risk of cancer encourages the “cascade” testing that can help to identify healthy people at risk of the disease, according to a new study by researchers at the Stanford University School of Medicine and Color, a health services […]Continue Reading ...
A new computer program can analyze images of patients’ lung tumors, specify cancer types, and even identify altered genes driving abnormal cell growth, a new study shows. Led by researchers at NYU School of Medicine and published online in Nature Medicine, the study found that a type of artificial intelligence (AI), or “machine learning” program, […]Continue Reading ...
Killer T cells surround a cancer cell. Credit: NIH Scientists at the VIB-UGent Center for Medical Biotechnology have taken important steps toward the development of cancer-targeting immunotherapy. The research team developed a treatment in mice that destroys part of the tumor and stimulates the immune system to attack persistent surviving cancer cells. In addition, the […]Continue Reading ...
Researchers from the University of Luxembourg have discovered a molecular mechanism that is responsible for the spread of cancer cells in the body and the development of metastases in patients with colon cancer. Their findings could help to develop treatments that inhibit tumor growth. Colorectal cancer (CRC) is among the most prevalent cancer types worldwide, […]Continue Reading ...
- Senators unveil legislation to protect patients against surprise medical bills
- Study provides insights into development of special-purpose cosmetic products
- Research shows enlarged genotype-phenotype correlation for three-base pair deletion in NF1
- Mediterranean-style diet appears to reduce stroke risk in women
- AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
- Characterization of pregnancy microbiome reveals variations in bacterial diversity
- New guidance for treatment of bone loss in hematologic stem cell transplant Recipients
- Experts to present research on prevention, management of dysphagia at international conference
- New study focuses on two-way gene switches controlling gene activity
- Zika virus could become a weapon against brain cancer
- Home-based video game exercises can reduce chronic low back pain in older people, study finds
- Investigators find that bile acids reduce cocaine reward
- Cannabinoid drugs reduce perceived unpleasantness of painful stimuli and increase tolerance
- Health care companies’ data could enable more accurate flu season forecasts
- Geroscience takes center stage in Journal of the American Medical Association
- Ambient Particulate Matter Linked to Emergency Asthma Care
- Patient satisfaction with plastic surgery—it’s the surgeon, not the practice
- Medicine is a team sport – and that’s exactly how it should be
- Logos Biosystems releases new electrophoretic tissue clearing system with twice the features in half the space
- Novel micro-platform reveals never-before-seen behaviors of cancer cells